Own Allkem shares? Here's the latest on its merger with Livent Corp

It may not be long until Allkem and Livent Corp turn into Arcadium Lithium.

| More on:
Black and white arrow joining together to make a bigger arrow symbolising mergers and acquisitions.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Allkem Ltd (ASX: AKE) shares are having a decent session on Thursday.

At the time of writing, the lithium miner's shares are up 2.5% to $9.51.

Why are Allkem shares pushing higher?

Investors have been buying the company's shares today after its proposed merger with Livent Corp (NYSE: LTHM) took a big step forward.

Yesterday afternoon, the company revealed that the Federal Court of Australia has approved the convening of a scheme meeting and the dispatch of the scheme booklet.

Allkem has since followed this up with an announcement this morning advising that the Australian Securities and Investments Commission (ASIC) has registered the notice of meeting and explanatory statement in relation to the proposed scheme of arrangement.

The release also reveals that the independent expert's report, which has been prepared by Kroll Australia, concludes that the scheme is in the best interests of Allkem shareholders. This is in the absence of a superior proposal.

Furthermore, Allkem's directors continue to unanimously recommend that shareholders vote in favour of the scheme. Once again, this is subject to no superior proposal and the independent expert continuing to conclude that it is in the best interest of shareholders.

What's next?

The scheme meeting will be held in Western Australia next month on 19 December.

If everything goes to plan, the scheme will then before effective on 21 December. After which, it will be implemented on 4 January.

Once everything is complete, shareholders will receive shares in the merged entity, which will be known as Arcadium Lithium.

As covered here, Bell Potter estimates that Arcadium Lithium will be a top-three global lithium producer following the completion of the merger. It has a buy rating and a $18.45 price target on its shares.

Motley Fool contributor James Mickleboro has positions in Allkem. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Two workers at an oil rig discuss operations.
Broker Notes

Should you buy Santos, Beach Energy or Woodside shares? Here's Macquarie's top pick

Macquarie has released its new share price expectations for Santos, Beach Energy and Woodside shares.

Read more »

A green fully charged battery symbol surrounded by green charge lights representing the surging Vulcan share price today
Share Market News

Up 300% in 6 months! This soaring ASX lithium stock just took a major step to production

Marching forward.

Read more »

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man pointing up looking amazed, indicating a surging share price movement for an ASX company
Share Market News

Macquarie says this top ASX tech stock could rise 15%

Let's see what the broker is saying about this stock.

Read more »

Excited couple celebrating success while looking at smartphone.
Healthcare Shares

Up 680% since July, here's why 2025 was a breakout year for this hot ASX stock

With consistent contract wins, FDA clearance, and backing from Pro Medicus, 4D Medical is showing that there is a commercial…

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Collins Foods, Monash IVF, Premier Investments, and Step One shares are tumbling today

These shares are ending the week in the red. But why?

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Share Gainers

4 ASX 200 stocks smashing the benchmark this week

Investors have been piling into these four ASX 200 stocks this week. Let’s see why.

Read more »